--- title: "CFOR.US (CFOR.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/CFOR.US/news.md" symbol: "CFOR.US" name: "CFOR.US" parent: "https://longbridge.com/en/quote/CFOR.US.md" datetime: "2026-03-10T06:36:32.863Z" locales: - [en](https://longbridge.com/en/quote/CFOR.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CFOR.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CFOR.US/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CFOR.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CFOR.US/news.md) # CFOR.US (CFOR.US) — Related News ### [03:15 ETgenOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model](https://longbridge.com/en/news/277004187.md) *2026-02-26T08:15:36.000Z* > genOway has developed a unique mouse model, genO-hFcγR, which enhances the prediction of therapeutic antibody efficacy a ### [Enanta Pharmaceuticals Inc. Announces Date for Upcoming Annual Meeting of Stockholders](https://longbridge.com/en/news/273746401.md) *2026-01-26T21:06:46.000Z* > Enanta Pharmaceuticals Inc. has announced that its 2026 Annual Meeting of Stockholders will take place virtually on Marc ### [OpGen Inc Announces Resignation of President](https://longbridge.com/en/news/270660184.md) *2025-12-23T22:13:00.000Z* > On December 18, 2025, OpGen Inc announced that David Lazar has resigned from his position as President, effective Januar ### [OpGen Inc. Extends $9 Million Private Placement Agreement with AEI Capital](https://longbridge.com/en/news/270659687.md) *2025-12-23T22:09:39.000Z* > OpGen Inc. has amended its Securities Purchase Agreement with AEI Capital Ltd., increasing potential financing to $9 mil ### [OpGen Inc. Files Initial Statement of Beneficial Ownership for CEO Christian-Laurent Bonte](https://longbridge.com/en/news/269314153.md) *2025-12-11T02:09:17.000Z* > OpGen Inc. has filed an initial statement of beneficial ownership with the U.S. SEC, listing CEO Christian-Laurent Bonte ### [OpGen (OTC:OPGN) Share Price Passes Above Fifty Day Moving Average - Should You Sell?](https://longbridge.com/en/news/268827058.md) *2025-12-06T09:17:31.000Z* > OpGen's stock (OTC:OPGN) crossed above its 50-day moving average, trading as high as $10.90, with a last price of $10.50 ### [OpGen (OTC:OPGN) Stock Crosses Above Fifty Day Moving Average - What's Next?](https://longbridge.com/en/news/266706013.md) *2025-11-20T10:02:03.000Z* > OpGen's stock price surged above its 50-day moving average, trading as high as $5.04, marking an 80% increase. Despite t ### [OpGen | 10-Q: FY2025 Q3 Revenue: USD 0](https://longbridge.com/en/news/266626047.md) *2025-11-19T22:18:23.000Z*